Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00203970
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-05-10
First Post:
2005-09-12
Brief Title:
Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services
Sponsor:
University of Chicago
Organization:
University of Chicago
Study Overview
Official Title:
Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research is to gain insight into the way in which physicians adopt new practice techniques In particular we are interested in how medical innovations diffuse throughout social networks We wish to examine the diffusion of Low Molecular Weight Heparin LMWH use for Deep Vein Thrombosis DVT throughout the social network of general internal medicine interns residents and attendings at the University of Chicago Hospital In numerous clinical trials LMWH has been demonstrated to be as effective as unfractionated heparin as a bridge to long-term anticoagulation therapy with Coumadin with the added benefit of early discharge from the hospital with easy dosing no need for monitoring and home therapy A DVT critical pathway was established at the U of C in 1998 and LMWH was used off-label for that purpose beginning in 1997 However it is unclear how quickly the use of LMWH was adopted by the physicians on the general medicine services or whether there exists a pattern for this adoption
Detailed Description:
The design of our study is retrospective in nature We are interested primarily in the use of LMWH in patients admitted to the general medicine services between January 1 1997 and February 1 2001 with a primary and secondary diagnosis related to Venous Thromboembolism including specific ICD-9 codes
Using a data abstraction form we gather the following information 1 patient demographics 2 identity of the attending resident and interns caring for the patient 3 whether the patient had any absolute or relative contraindications for receiving LMWH as delineated by the DVT critical pathway including insurance status and 4how the patient was treated for hisher condition To examine whether the identity of the primary care physician affects whether LMWH is given we also collect the name of the primary care physician if it is listed on the chart
Using a data abstraction form we gather the following information 1 patient demographics 2 identity of the attending resident and interns caring for the patient 3 whether the patient had any absolute or relative contraindications for receiving LMWH as delineated by the DVT critical pathway including insurance status and 4how the patient was treated for hisher condition To examine whether the identity of the primary care physician affects whether LMWH is given we also collect the name of the primary care physician if it is listed on the chart
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None